Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mycology

Candida Species Exhibit Differential In Vitro Hemolytic Activities

Gang Luo, Lakshman P. Samaranayake, Joyce Y. Y. Yau
Gang Luo
Oral Bio-Sciences, Faculty of Dentistry, The University of Hong Kong, Hong Kong, Special Administrative Region, and
College of Stomatology, West China University of Medical Sciences, Chengdu, People's Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakshman P. Samaranayake
Oral Bio-Sciences, Faculty of Dentistry, The University of Hong Kong, Hong Kong, Special Administrative Region, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce Y. Y. Yau
Oral Bio-Sciences, Faculty of Dentistry, The University of Hong Kong, Hong Kong, Special Administrative Region, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.39.8.2971-2974.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A total of 80 Candida isolates representing 14 species were examined for their respective responses to an in vitro hemolytic test. A modification of a previously described plate assay system where the yeasts are incubated on glucose (3%)-enriched sheep blood agar in a carbon dioxide (5%)-rich environment for 48 h was used to evaluate the hemolytic activity. A group of eight Candidaspecies which included Candida albicans (15 isolates),C. dubliniensis (2), C. kefyr(2), C. krusei (4), C. zeylanoides (1), C. glabrata(34), C. tropicalis (5), andC. lusitaniae (2) demonstrated both alpha and beta hemolysis at 48 h postinoculation. Only alpha hemolysis was detectable in four Candida species, viz., C. famata (3), C. guilliermondii(4), C. rugosa (1), and C. utilis (1), while C. parapsilosis (5) and C. pelliculosa (1) failed to demonstrate any hemolytic activity after incubation for 48 h or longer. This is the first study to demonstrate the variable expression profiles of hemolysins by different Candida species.

Candida species have the ability to produce a variety of hydrolytic enzymes, such as proteases, lipases, phospholipases, esterases, and phosphatases (4, 11, 13). These enzymes have received much attention in the past, as they are known to mediate candidal pathogenesis, particularly by facilitating the hyphal invasion especially seen in disseminated candidiasis (6). While there have been a number of detailed studies on some of these hydrolytic enzymes, such as proteases, lipases, and phospholipases (8, 9, 14), little is known of the hemolytic activity exhibited by differentCandida species. Recently, Manns et al. (10) described an elegant yet simple plate assay method for observing the hemolytic activity of Candida albicans. We have modified this method to evaluate the hemolytic activity of differentCandida species obtained from a variety of clinical sources and to compare qualitatively and quantitatively the species-specific differences in hemolysin production.

A total of 80 Candida isolates representing 14 differentCandida species obtained from clinical sources in different geographic locales were selected from strains deposited at theCandida Culture Collection of the Oral Bio-Sciences Laboratory, Faculty of Dentistry, The University of Hong Kong, Hong Kong (Table 1). For global comparison of data, a single reference laboratory strain each of C. albicans ATCC 90028, C. glabrata ATCC 2001, and C. parapsilosis ATCC 22019 (American Type Culture Collection, Rockville, Md.) were also included. The identity of all organisms was reconfirmed by the germ tube test, and the commercially available API 20C Aux identification kit (Analytical Profile Index; BioMerieux SA, Marcy l'Etoile, France) (13). Stock cultures were maintained at −40°C. After recovery these were maintained on Sabouraud dextrose agar (Oxoid Ltd, Basingstoke, Hampshire, England, United Kingdom) and stored at 4 to 6°C during the experimental period. Purity of cultures was ensured by regular random identification of isolates by techniques described above. In addition to the yeast strains, one strain each ofStreptococcus pyogenes (Lancefield group A) andStreptococcus sanguis, which induce beta and alpha hemolysis, respectively, were used as positive controls.

View this table:
  • View inline
  • View popup
Table 1.

Hemolytic activity of 14 different Candidaspecies isolated from human sourcesa

Hemolysin production was evaluated using a modification of the plate assay described by Manns et al. (10). In brief, the isolates were recovered from distilled water stored at −40°C. A loopful of the stock culture was streaked onto Sabouraud dextrose agar and incubated at 37°C for 18 h. The resultant cultures were harvested and washed with sterile saline, and a yeast suspension with an inoculum size of 108 cells/ml was prepared using hemocytometric counts (12). Ten microliters of this suspension was spot inoculated on a sugar-enriched sheep blood agar medium so as to yield a circular inoculation site of about 5 mm in diameter. The latter medium was prepared by adding 7 ml of fresh sheep blood (Hemostat, Dixon, Calif.) to 100 ml of Sabouraud dextrose agar supplemented with 3% glucose (final concentration, wt/vol; Merck, Darmstadt, Germany). The final pH of the medium so prepared was 5.6 ± 0.2. The plates were incubated at 37°C in 5% CO2 for 48 h. The presence of a distinct translucent halo around the inoculum site, viewed with transmitted light, indicated positive hemolytic activity. The diameters of the zones of lysis and the colony were measured with the aid of a computerized image analysis system (Quantimet 500 Qwin; Leica, Cambridge, United Kingdom) (18), and this ratio (equal to or larger than 1) was used as a hemolytic index to represent the intensity of the hemolysin production by different Candidaspecies. The assay was conducted in quadruplicate on two separate occasions for each yeast isolate tested.

An additional experiment was performed to determine the effect of the glucose supplement on the hemolysin production by incubating a total of 12 hemolysin-positive yeasts in glucose-free blood agar medium.

At 48 h postinoculation, two different types of hemolysis could be observed circumscribing the yeast “colony” when viewed with transmitted light (Fig. 1). The first was a totally translucent ring identical to beta hemolysis produced by the control strain of beta-hemolytic S. pyogenes, and the second was a greenish-black halo comparable to alpha-hemolysis observed with the control strain of S. sanguis. Hence, the terms alpha hemolysis and beta hemolysis were used as descriptive terms to indicate incomplete and complete hemolysis, respectively, associated with theCandida strains tested.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Photographs depicting the hemolysis of sheep blood agar (supplemented with 3% glucose) induced by 14 differentCandida species. Panel a shows C. albicans (A),C. glabrata (B), C. parapsilosis (C),C. tropicalis (D), C. lusitaniae (E), C. zeylanoides (F), C. guilliermondii (G), and C. famata (H). Panel b shows C. kefyr (A), C. pelliculosa (B), C. dubliniensis (C), C. utilis (D), C. parapsilosis (E), C. albicans (F), C. krusei (G), and C. rugosa(H). A reference strain of C. albicans (ATCC90028) served as a positive control (I).

At 24 h postinoculation, only alpha hemolysis was observed surrounding the inoculum sites with all strains of theCandida spp. C. albicans, C. dubliniensis, C. kefyr, C. krusei, C. zeylanoides, C. glabrata, C. tropicalis, andC. lusitaniae. However, after further incubation for 48 h the zone of hemolysis enlarged and showed dual zones, i.e., an internal zone of beta hemolysis surrounded by a peripheral zone of alpha hemolysis (Fig. 1).

A total of nine Candida isolates belonging to C. famata, C. guilliermondii, C. rugosa, and C. utilis exhibited only a zone of alpha hemolysis despite prolonged inoculation (i.e., 72 h). On the contrary, all tested isolates ofC. parapsilosis and a single isolate of C. peliculosa exhibited neither alpha nor beta hemolysis despite 72 h of incubation (Table 1).

As opposed to the hemolytic patterns described above for glucose-supplemented media, in experiments with glucose-free sheep blood agar, all tested strains except those of C. parapsilosis and C. pelliculosa exhibited only alpha hemolysis. The last two species produced neither alpha nor beta hemolysis.

In order to obtain quantitative data we attempted to measure the diameters of hemolytic zones relative to the inoculum size using an image analysis system. However, clear-cut zones were perceptible only in relation to beta-hemolytic activity. The margins of alpha hemolysis were rather diffuse, and hence the diameters of the latter zones were not accurately quantifiable by either naked eye estimation or the image analysis system.

The quantitative data indicated that the beta-hemolytic activities ofC. albicans, C. dubliniensis, C. kefyr, and C. tropicalis were significantly higher than those of C. glabrata, C. krusei, and C. lusitaniae(P < 0.05) (Fig. 2 and Table 1). Although C. zeylanoides showed a much higher beta-hemolytic activity than all other tested species, this result was equivocal as only a single strain was examined (Table 1). Further, there was no significant intraspecies differences in the beta-hemolytic activity among isolates belonging to C. albicans and C. glabrata. Similar statistics could not be performed for the remaining species due to the small number of isolates tested in each species.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Histogram depicting the beta-hemolytic activity of seven different Candida species (the diameter of the translucent radial zone of hemolysis divided by the diameter of the colony size).C. albicans (Ca), C. dubliniensis (Cd), C. kefyr (Cky), and C. tropicalis (Ct) exhibited a significantly higher beta-hemolytic activity than C. glabrata (Cg), C. lusitaniae (Cl), and C. krusei (Ckr) (P < 0.05) ; bar represents ± 1 standard deviation. The number of strains in each species is indicated in parenthesis. (A beta hemolysis positive species, C. zeylanoides, is not shown here since only a single strain of this species was investigated.)

The ability of pathogenic organisms to acquire elemental iron has been shown to be of pivotal importance in their survival and ability to establish infection within the mammalian host (3, 17). Since there is essentially no free iron in the human host, most pathogens acquire this indirectly from commonly available iron-containing compounds such as hemoglobin (2). In order to do so, however, the pathogen should be equipped with a mechanism that destroys the heme moiety and enables it to extract the elemental iron. The enzymes mediating such activity are broadly classified as hemolysins.

A complement-mediated hemolysis induced by C. albicans was reported by Manns et al. in 1994 (10), but a perusal of the literature revealed no other reports on the hemolytic activity of non-albicans species of Candida. In the present study, we conclusively demonstrate, both qualitatively and quantitatively the hemolytic activity in a wide spectrum ofCandida species belonging to 14 genera. The hemolysis so induced could be categorized according to the conventional microbiologic nomenclature as either complete (beta), incomplete (alpha), or no hemolysis (gamma). Thus the terms alpha and beta hemolysis used here to describe the different patterns of hemolysis inCandida species can only be regarded as descriptive, since the exact nature of these variants and the underlying mechanisms are yet to be explored in full.

Of the tested Candida species, C. albicans, C. dubliniensis, C. kefyr, C. krusei, C. zeylanoides, C. glabrata, C. tropicalis, and C. lusitaniaedemonstrated both alpha and beta hemolysis. However, beta-hemolytic activity in these species was seen only after 48 h followed by alpha hemolysis on 24 h of incubation, whereas C. famata, C. guilliermondii, C. rugosa, and C. utilisdemonstrated only alpha-hemolytic activity despite prolonged inoculation. These observations appear to suggest that alpha- and beta-hemolytic activity may be a result of two or more different hemolytic factors sequentially produced by the yeasts. Thus, it is tempting to hypothesize that the erythrocytes are destroyed by a two-stage mechanism. First would be a partial destruction due to an alpha-hemolytic factor(s) generated by the relatively young colonies ofCandida. Thus, the metabolic end products of the first stage may serve as a catalyst to induce the secretion of a secondary hemolytic factor(s), beta hemolysin, leading to complete destruction of hemoglobin. This hypothesis accommodates our observations related to both the alpha- and beta-hemolytic species of Candida, since some species may be devoid of an enzymatic pathway necessary to accomplish complete hemolytic activity.

The nature of the alpha-hemolytic factor(s) in microorganisms is poorly understood. Hemolysins are known to be key virulence factors contributing to the pathogenesis of common bacterial infections due to staphylococci and streptococci. In a recent study, Barnard and Stinson (1) demonstrated that the alpha-hemolytic factor inStreptococcus gordonii is hydrogen peroxide. AlthoughC. albicans is capable of generating hydrogen peroxide (5), it is unclear whether the latter is responsible for alpha hemolysis observed in the present study. Further studies are needed to determine whether hydrogen peroxide can also be produced by non-albicans Candida species which exhibited alpha hemolysis and to examine the possible relationship, if any, between these two parameters.

Although Manns et al. (10) described a translucent complete hemolytic ring induced by C. albicans, identical to the beta hemolysis observed by us, yet again there is no biochemical information on the beta-hemolytic factors released byCandida species. It may be questioned whether the hemolytic activity observed is true hemolysis or is a product of extracellular phospholipases of Candida species. This is unlikely to be the case, since only 26.4% of the 34 C. glabrata isolates used in the present study were phospholipase positive when tested by an in vitro egg yolk agar assay (unpublished data). Watanabe et al. (15) have proposed that the beta hemolysin in C. albicans is probably a cell wall mannoprotein. However, our observations cast doubt on this hypothesis, since 6 of 14 Candida species we tested were unable to produce beta hemolysis, although mannoprotein is a universal component of the Candida cell wall. One possible explanation for these disparate observations is likely to be the variation in the cell wall mannoprotein content among different Candida species. Furthermore, when the hemolytic assay was performed using a glucose-free medium, only alpha hemolysis was observed with the previously beta-hemolytic Candida species. Thus, it appears that the absence of glucose in the medium may have altered the sugar moiety of the mannoprotein in some manner leading to the loss of beta-hemolytic activity.

Although we have compared quantitatively the relative zone sizes of beta hemolysis among Candida species and the data showed that C. albicans, C. dubliniensis, C. kefyr, and C. tropicalis exhibited significantly higher beta-hemolytic activities than other species, it should be borne in mind that there may exist species-specific hemolysins that may vary in their molecular size and thus affect the diffusion rate. Further studies are warranted to evaluate these molecular differences, if any, inCandida hemolysins.

C. albicans is a dimorphic yeast and exists in both the hyphal and the blastoconidial phases, depending on the growth medium and conditions. Previous workers have reported that hemolysin is produced by C. albicans only when it is in the hyphal form and not in the blastoconidial form (16). We doubt whether the hyphal form is a prerequisite for hemolysin production, since both alpha and beta hemolysis were observed with all strains ofC. glabrata, considered a hyphae-negative species (7).

The modified plate assay described in the present report is simple, reproducible, and sensitive and is a relatively fast screening method for assessing the hemolytic activity of Candida species. In clinical terms, it could be of interest to evaluate the relationship between the virulence and the degree of hemolysin production among pathogenic and commensal isolates of Candida using this method. Such studies are in progress in our laboratories.

To conclude, the findings reported here for the first time indicate that many Candida species exhibit various abilities to produce one or more types of hemolysins, the nature of which is ill understood at present. Of the common pathogenic species, C. albicans and C. dubliniensis appear to be the most prolific producers of hemolysins, in keeping with the foremost position they occupy in the hierarchy of virulence amongst Candidaspecies. Further studies are urgently needed to investigate the nature of the hemolytic factors secreted by Candida, their utility in diagnostic terms and, last but not the least, their putative effects in the human host.

ACKNOWLEDGMENTS

This research was supported by the Research Grants Council (RGC) of Hong Kong and the Committee for Research and Conference Grants (CRCG), of the University of Hong Kong, Hong Kong.

We thank A. Ellepola, S. Anil, R. Dassanayake, and G. Tang for their valuable discussions and Becky Cheung for her excellent technical support.

FOOTNOTES

    • Received 21 March 2001.
    • Returned for modification 2 May 2001.
    • Accepted 3 June 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Barnard J. P.,
    2. Stinson M. W.
    The alpha-hemolysin of Streptococcus gordonii is hydrogen peroxide.Infect. Immun.64199638533857
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Belanger M.,
    2. Begin C.,
    3. Jacques M.
    Lipopolysaccharides of Actinobacillus pleuropneumoniae bind pig hemoglobin.Infect. Immun.631995656662
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Bullen J. J.
    The significance of iron in infection.Rev. Infect. Dis.3198111271138
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Cutler J. E.
    Putative virulence factors of Candida albicans.Annu. Rev. Microbiol.451991187218
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Danley D. L.,
    2. Hilger A. E.,
    3. Winkel C. A.
    Generation of hydrogen peroxide by Candida albicans and influence on murine polymorphonuclear leukocyte activity.Infect. Immun.40198397102
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Fallon K.,
    2. Bausch K.,
    3. Noonan J.,
    4. Huguenel E.,
    5. Tamburini P.
    Role of aspartic proteases in disseminated Candida albicans infection in mice.Infect. Immun.651997551556
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Fidel P. L. Jr.,
    2. Vazquez J. A.,
    3. Sobel J. D.
    Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.Clin. Microbiol. Rev.1219998096
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Hube B.,
    2. Turver C. J.,
    3. Odds F. C.,
    4. Eiffert H.,
    5. Boulnois G. J.,
    6. Kochel H.,
    7. Ruchel R.
    Identification, cloning and characterization of the gene for the secretory aspartate protease of Candida albicans. Mycoses 34 (Suppl. 1) 1991 59 61
    OpenUrl
  9. 9.↵
    1. Lee G. C.,
    2. Tang S. J.,
    3. Sun K. H.,
    4. Shaw J. F.
    Analysis of the gene family encoding lipases in Candida rugosa by competitive reverse transcription-PCR.Appl. Environ. Microbiol.65199938883895
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Manns J. M.,
    2. Mosser D. M.,
    3. Buckley H. R.
    Production of a hemolytic factor by Candida albicans.Infect. Immun.62199451545156
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Odds F. C.
    Candida and candidosis: a review and bibliography 2nd ed. 1988 Bailliere Tindall London, United Kingdom
  12. 12.↵
    1. Samaranayake L. P.,
    2. MacFarlane T. W.
    The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitro.Arch. Oral Biol.261981815820
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Samaranayake L. P.,
    2. MacFarlane T. W.
    Oral candidosis. 1990 Wright Bristol, United Kindom
  14. 14.↵
    1. Takahashi M.,
    2. Banno Y.,
    3. Nozawa Y.
    Secreted Candida albicans phospholipases: purification and characterization of two forms of lysophospholipase-transacylase.J. Med. Vet. Mycol.291991193204
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Watanabe T.,
    2. Takano M.,
    3. Murakami M.,
    4. Tanaka H.,
    5. Matsuhisa A.,
    6. Nakao N.,
    7. Mikami T.,
    8. Suzuki M.,
    9. Matsumoto T.
    Characterization of a haemolytic factor from Candida albicans.Microbiology1451999689694
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Watanabe T.,
    2. Takano M.,
    3. Murakami M.,
    4. Tanaka H.,
    5. Matsuhisa A.,
    6. Nakao N.,
    7. Mikami T.,
    8. Suzuki M.,
    9. Matsumoto T.
    Hemoglobin is utilized by Candida albicans in the hyphal form but not yeast form.Biochem. Biophys. Res. Commun:2321997350353
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Weinberg E. D.
    Iron and infection.Microbiol. Rev.4219784566
    OpenUrlFREE Full Text
  18. 18.↵
    1. Wu T.,
    2. Samaranayake L. P.,
    3. Cao B. Y.,
    4. Wang J.
    In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents.J. Med. Microbiol.441996311316
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Candida Species Exhibit Differential In Vitro Hemolytic Activities
Gang Luo, Lakshman P. Samaranayake, Joyce Y. Y. Yau
Journal of Clinical Microbiology Aug 2001, 39 (8) 2971-2974; DOI: 10.1128/JCM.39.8.2971-2974.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Candida Species Exhibit Differential In Vitro Hemolytic Activities
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Candida Species Exhibit Differential In Vitro Hemolytic Activities
Gang Luo, Lakshman P. Samaranayake, Joyce Y. Y. Yau
Journal of Clinical Microbiology Aug 2001, 39 (8) 2971-2974; DOI: 10.1128/JCM.39.8.2971-2974.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Candida
candidiasis
Hemolysis

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X